Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study-Reference-Cited by-同舟云学术

Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study

Published:2018-03 Issue:3 Volume:19 Page:347-355
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Giaccone Giuseppe,Kim Chul,Thompson Jillian,McGuire Colleen,Kallakury Bhaskar,Chahine Joeffrey J,Manning Maria,Mogg Robin,Blumenschein Wendy M,Tan Ming T,Subramaniam Deepa S,Liu Stephen V,Kaplan Ian M,McCutcheon Justine N

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Epidemiology of thymoma and associated malignancies;Engels;J Thorac Oncol,2010

2. Thymic carcinoma: a cohort study of patients from the European Society of Thoracic Surgeons database;Ruffini;J Thorac Oncol,2014

3. Thymic malignancies: from clinical management to targeted therapies;Kelly;J Clin Oncol,2011

4. Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial;Thomas;Lancet Oncol,2015

5. Pembrolizumab for the treatment of non-small-cell lung cancer;Garon;N Engl J Med,2015

Cited by 295 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymic epithelial tumor medical treatment: A narrative review;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Lenvatinib in combination with pembrolizumab in heavily pretreated metastatic thymic carcinoma: A case report;Current Problems in Cancer: Case Reports;2024-09

3. Evolving treatment landscape in thymic epithelial tumors: From mechanism to therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. Depiction of the Genetic Alterations and Molecular Landscapes of Thymic Epithelial Tumors: A Systematic Review and Meta-Analysis;Cancers;2024-08-25

5. Clinical Characteristics of 34 Cases Diagnosed as Thymic Carcinoma in Our Institution;Haigan;2024-08-20